Largecap BioPharma have spent $36B on acquisitions for shiny sexy cell and gene therapy$GILD > $KITE $12B$CELG > $JUNO $10B$NVS > $AVXS $9BRoche > $ONCE $5BWill any of these deals generate a positive returnThe first two not looking so hot

Large-cap BioPharma have spent ~$36B on acquisitions for shiny sexy cell and gene therapy: $GILD -> $KITE $12B $CELG -> $JUNO $10B $NVS -> $AVXS $9B Roche -> $ONCE $5B Will any of these deals generate a positive return? The first two not looking so hot

08:46 EST 25 Feb 2019 | Andy Biotech

Large-cap BioPharma have spent ~$36B on acquisitions for shiny sexy cell and gene therapy: $GILD -> $KITE $12B $CELG -> $JUNO $10B $NVS -> $AVXS $9B Roche -> $ONCE $5B Will any of these deals generate a positive return? The first two not looking so hot so far...